Skip to main content
. 2024 Feb 25;16(3):321. doi: 10.3390/pharmaceutics16030321

Table 2.

Critical quality attributes (CQA) and similarity demonstration products [12,40].

Comparability Critical Attributes Similarity Demonstration
Protein structure and production quality Extensive laboratory analysis for all molecular characteristics (multiple lots)
Pharmacokinetics, Pharmacodynamics, and Animal Toxicity In vitro and in vivo assays (carried out on relevant animal species, if further confirmation scans are required for laboratory studies)
Pharmacokinetics, Pharmacodynamics, and Animal Toxicity Phase I clinical studies
Clinical Efficacy and Safety Phase III clinical studies
Safety in clinical practice Risk management plan
Phase IV studies
Pharmacovigilance